Correlation Between Abcellera Biologics and PacifiCorp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and PacifiCorp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and PacifiCorp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcellera Biologics and PacifiCorp, you can compare the effects of market volatilities on Abcellera Biologics and PacifiCorp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of PacifiCorp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and PacifiCorp.

Diversification Opportunities for Abcellera Biologics and PacifiCorp

0.25
  Correlation Coefficient

Modest diversification

The 3 months correlation between Abcellera and PacifiCorp is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and PacifiCorp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PacifiCorp and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with PacifiCorp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PacifiCorp has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and PacifiCorp go up and down completely randomly.

Pair Corralation between Abcellera Biologics and PacifiCorp

Given the investment horizon of 90 days Abcellera Biologics is expected to generate 1.13 times less return on investment than PacifiCorp. In addition to that, Abcellera Biologics is 3.05 times more volatile than PacifiCorp. It trades about 0.07 of its total potential returns per unit of risk. PacifiCorp is currently generating about 0.24 per unit of volatility. If you would invest  13,495  in PacifiCorp on November 3, 2024 and sell it today you would earn a total of  1,850  from holding PacifiCorp or generate 13.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy97.56%
ValuesDaily Returns

Abcellera Biologics  vs.  PacifiCorp

 Performance 
       Timeline  
Abcellera Biologics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics disclosed solid returns over the last few months and may actually be approaching a breakup point.
PacifiCorp 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in PacifiCorp are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain essential indicators, PacifiCorp displayed solid returns over the last few months and may actually be approaching a breakup point.

Abcellera Biologics and PacifiCorp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abcellera Biologics and PacifiCorp

The main advantage of trading using opposite Abcellera Biologics and PacifiCorp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, PacifiCorp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PacifiCorp will offset losses from the drop in PacifiCorp's long position.
The idea behind Abcellera Biologics and PacifiCorp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance